Sun Pharma shares have given subdued returns to investors so far in 2025. The stock is down over 8.5% this year and 6% in May 2025. US trade tariff threats have impacted the Sun Pharma stock performance.

EBITDA margin is expected to improve on the back of higher sales of the Revlimid, gRevlimid, and Taro pharm drug and sustained growth in domestic formulations.

Pharma major, Sun Pharmaceutical Industries, will announce its March quarter results today. The results are expected to be announced after market hours followed by analyst/ investor meeting.

In the December (Q3FY25) quarter, Sun Pharma registered a consolidated net profit of ₹2,913 crore, up 13% YoY, while its revenue from operations stood at ₹13,675 crore, up 10% YoY during the same period. The company reported revenue of ₹11,983 crore in Q4FY24 and net profit of ₹2,659 crore.

The pharma company's board has recommended a final dividend of ₹4 per equity share of ₹10 each (at the rate of 40%) for the financial year ending March 31, 2025. "Dividends will be paid within 30 days from the date of shareholders’ approval at the ensuing Annual General Meeting (AGM)," Strides Pharma said.

• Revenue at ₹1,190.39 crore versus ₹1,043.50 crore, UP 14.1%

• Net profit at ₹82.19 crore versus ₹18.18 crore, UP 352%

• EBITDA at ₹217.86 crore versus ₹204.32 crore, UP 7%

• Margin at 18.3% versus 19.6%

The company's board has recommended a final dividend of ₹4 (400%) per equity share of the face value of ₹1 each for the financial year ending March 31, 2025. "The final dividend is subject to the approval of the members at the ensuing Annual General Meeting, which will be held within the stipulated timeline as per the provisions of the Companies Act, 2013," the firm said.

• Revenue at ₹263.6 crore versus ₹227.5 crore, UP 15.8%.

• Net profit at ₹74.09 crore versus ₹70.2 crore, UP 5.7%.

• EBITDA at ₹105 crore versus ₹95 crore, UP 10.6%.

• Margin at 39.8% versus 41.7%

The technical structure of the ITC remains weak as it trades below its 200-day exponential moving average (EMA) for five months. Additionally, it is facing resistance from the downward sloping trendline connecting its all-time high and January siwng high.

The FMCG major ITC is expected to report mixed earnings, with low single-digit revenue growth and a decline in net profit. Experts believe ITC is likely to post a 1–3% year-on-year (YoY) increase in standalone revenue, reaching ₹16,500–₹16,850 crore. This growth is expected to be driven by higher sales in its FMCG and cigarettes segments.

However, profitability may be under pressure. Net profit is projected to decline 6–8% YoY to ₹4,600–₹4,700 crore, largely due to margin compression from rising raw material costs.

• Accedere
• Adishakti Loha and Ispat
• Adroit Infotech
• Advance Multitech
• Advance Petrochemicals
• AKI India
• Aksh Optifibre
• Alankit
• Alexander Stamps and Coin
• Archidply Industries
• Aries Agro
• Ashiana Agro Industries
• Asia Pack
• Astra Microwave Products
• Bajel Projects
• Barbeque-Nation Hospitality
• Bharat Gears
• Bloom Industries
• Blue Coast Hotels
• BSL
• Cargosol Logistics
• Centum Electronics
• Chowgule Steamships
• Clean Science and Technology
• Capital Trade Links
• DAPS Advertising
• Deepak Fertilisers & Petrochemicals Corporation
• Deepak Spinners
• Dhunseri Tea & Industries
• Dwarikesh Sugar Industries
• Eldeco Housing & Industries
• Emami Realty
• Emerald Finance
• Emerald Leisures
• Expleo Solutions
• Fervent Synergies
• Flair Writing Industries
• Gandhar Oil Refinery (India)
• Geetanjali Credit and Capital
• Gujarat Industries Power Company
• GOCL Corporation
• Golden Carpets
• Goodluck India
• Grasim Industries
• Graviss Hospitality
• Greenpanel Industries
• Growington Ventures India
• Gujarat State Petronet
• Haryana Capfin
• HFCL
• Hindustan Motors
• HLV
• HPL Electric & Power
• Hubtown
• India Finsec
• Igarashi Motors India
• India Gelatine & Chemicals
• Indo Amines
• Indoco Remedies
• Indus Finance
• Integra Switchgear
• Investment & Precision Castings
• Iykot Hitech Toolroom
• Jai Mata Glass
• Jay Bharat Maruti
• Jet Solar
• Jigar Cables
• JSL Industries
• Jupiter Infomedia
• Kabsons Industries
• Kaira Can Company
• Kiran Syntex
• Kriti Industries India
• Kriti Nutrients
• Kronox Lab Sciences
• Labelkraft Technologies
• Lincoln Pharmaceuticals

As many as 164 companies will post their earnings number for the fourth quarter of the financial year 2024-25 on Thursday, May 22. This includes Container Corporation of India (CONCOR), Emcure Pharmaceuticals, GMR Airports, Honasa Consumers, ITC Ltd, Max Estates, The Ramco Cements, Reliance Home Finance, Sun Pharmaceuticals and Strides Pharma Science.